- Home
- PLNT vs LNTH Comparison
PLNT vs LNTH Comparison
Compare PLNT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLNT | LNTH |
|---|---|---|
| Founded | 1992 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 4.4B |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PLNT | LNTH |
|---|---|---|
| Price | $109.61 | $65.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $118.77 | $77.33 |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.23 | N/A |
| EPS | ★ 2.44 | 2.39 |
| Revenue | $1,202,700,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $21.34 | $0.01 |
| Revenue Next Year | $11.14 | $1.24 |
| P/E Ratio | $44.50 | ★ $27.84 |
| Revenue Growth | ★ 14.63 | 1.95 |
| 52 Week Low | $87.72 | $47.25 |
| 52 Week High | $114.47 | $111.29 |
Technical Indicators
Market Signals| Indicator | PLNT | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 66.33 |
| Support Level | $107.86 | $60.15 |
| Resistance Level | $109.98 | $67.40 |
| Average True Range (ATR) | 2.53 | 1.98 |
| MACD | -0.40 | 0.63 |
| Stochastic Oscillator | 38.86 | 77.40 |
Price Performance
Historical ComparisonAbout PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.